Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria:: A prospective study

被引:278
作者
Gerber, A
Karch, H
Allerberger, F
Verweyen, HM
Zimmerhackl, LB
机构
[1] Univ Freiburg, Zentrum Kinderheilkunde & Jugendmed, Freiburg, Germany
[2] Univ Munster, Inst Hyg, D-4400 Munster, Germany
[3] Univ Innsbruck, Inst Hyg, Innsbruck, Austria
关键词
D O I
10.1086/341940
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hemolytic-uremic syndrome (HUS) is mainly associated with foodborne infections by Shiga toxin-producing Escherichia coli (STEC). From January 1997 through December 2000, 394 children with HUS were evaluated in a prospective multicenter surveillance study in Germany and Austria (incidences, 0.7/100,000 and 0.4/100,000 children <15 years old, respectively). Blood leukocytosis was associated with increased detection of STEC in stool cultures (P < .01) and a more severe disease course. Risk of death was associated with cerebral involvement (P < .01). Most strikingly, non-O157:H7 STEC were detected in 43% of stool cultures of patients with HUS: O26 was detected in 15%, sorbitol-fermenting O157:H(-) in 10%, O145 in 9%, O103 in 3%, and O111 in 43%. Patients with O157:H7 serotypes required dialysis for a longer time and had bloody diarrhea detected more frequently, compared with patients with non-O157:H7 serotypes (P < .05). This large study in children with HUS underlines the rising importance of non-O157:H7 serotypes, and, despite increased public awareness, the number of patients remained unchanged.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 40 条
[1]  
Allerberger F, 1997, WIEN KLIN WOCHENSCHR, V109, P669
[2]   The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical, and epidemiologic findings [J].
Banatvala, N ;
Griffin, PM ;
Greene, KD ;
Barrett, TJ ;
Bibb, WF ;
Green, JH ;
Wells, JG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07) :1063-1070
[3]   Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis [J].
Berner, R ;
Krause, MF ;
Gordjani, N ;
Zipfel, PF ;
Boehm, N ;
Krueger, M ;
Brandis, M ;
Zimmerhackl, LB .
PEDIATRIC NEPHROLOGY, 2002, 17 (03) :190-192
[4]   THE ROLE OF ESCHERICHIA-COLI O-157 INFECTIONS IN THE CLASSICAL (ENTEROPATHIC) HEMOLYTIC UREMIC SYNDROME - RESULTS OF A CENTRAL-EUROPEAN, MULTICENTER STUDY [J].
BITZAN, M ;
LUDWIG, K ;
KLEMT, M ;
KONIG, H ;
BUREN, J ;
MULLERWIEFEL, DE .
EPIDEMIOLOGY AND INFECTION, 1993, 110 (02) :183-196
[5]   HIGH-INCIDENCE OF SERUM ANTIBODIES TO ESCHERICHIA-COLI O157 LIPOPOLYSACCHARIDE IN CHILDREN WITH HEMOLYTIC-UREMIC SYNDROME [J].
BITZAN, M ;
MOEBIUS, E ;
LUDWIG, K ;
MULLERWIEFEL, DE ;
HEESEMANN, J ;
KARCH, H .
JOURNAL OF PEDIATRICS, 1991, 119 (03) :380-385
[6]  
BOCKEMUHL J, 1992, ZBL BAKT-INT J MED M, V276, P189
[7]   Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome [J].
Buteau, C ;
Proulx, F ;
Chaibou, M ;
Raymond, D ;
Clermont, MJ ;
Mariscalco, MM ;
Lebel, MH ;
Seidman, E .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (07) :642-647
[8]   COMMUNITY-WIDE OUTBREAK OF HEMOLYTIC-UREMIC SYNDROME-ASSOCIATED WITH NON-O157 VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI [J].
CAPRIOLI, A ;
LUZZI, I ;
ROSMINI, F ;
RESTI, C ;
EDEFONTI, A ;
PERFUMO, F ;
FARINA, C ;
GOGLIO, A ;
GIANVITI, A ;
RIZZONI, G .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :208-211
[9]   Non-O157 Shiga toxin-producing Escherichia coli infections in Europe [J].
Caprioli, A ;
Tozzi, AE ;
Rizzoni, G ;
Karch, H .
EMERGING INFECTIOUS DISEASES, 1997, 3 (04) :578-579
[10]   SIMULTANEOUS IDENTIFICATION OF STRAINS OF ESCHERICHIA-COLI SEROTYPE O157-H7 AND THEIR SHIGA-LIKE TOXIN TYPE BY MISMATCH AMPLIFICATION MUTATION ASSAY-MULTIPLEX PCR [J].
CEBULA, TA ;
PAYNE, WL ;
FENG, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :248-250